Oncology ⋆ Page 25 of 47 ⋆ eMEDICAL BOOKS

Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation 1st ed

November 10, 2017

[amazon template=image&asin=3319537881]

This volume provides a concise yet comprehensive overview of patient safety issues and quality improvement for the pediatric hematology/oncology/stem cell transplant practice. The book reviews patient safety in complex healthcare delivery systems, delineates the various safety issues affecting pediatric hematology/oncology patients, and discusses quality improvement methods and improvement science that allow the reader to implement and sustain change in their home institution. The text also explores mechanisms to measure quality and safety outcomes, allowing the provider to implement proven processes shown to minimize harm to patients.

Written by experts in the field, Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation is a valuable resource for healthcare professionals treating pediatric hematology, oncology and stem cell transplant patients.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FiYTSnD

Merkel Cell Carcinoma

November 9, 2017

[amazon template=image&asin=1461466075]

Merkel Cell Carcinoma is one of the first comprehensive, single-source clinical texts on the subject. Although not as common as melanoma, Merkel cell carcinoma is not rare – and it is both more deadly than melanoma and increasing at an epidemic rate. The book is clinical in focus and emphasizes treatment of this poorly understood cancer. Contributing authors include dermatologists, surgical oncologists, radiation oncologists, and medical oncologists from the US and around the world.

Features:

· Comprehensive single-source clinical reference

· Treatment focus

· Written for practitioners, with emphasis on clinical relevance and quick retrieval of information

· Contributing authors represent all disciplines involved in treatment of Merkel cell carcinoma: dermatology, surgical oncology, radiation oncology, and medical oncology

· International in perspective, with contributors from US and abroad

· Members of active Merkel Cell Carcinoma Multicenter Interest Group have authored some of the chapters

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FiDz4aa

Oncology

Tumors of the Jugular Foramen 1st ed. 2017 Edition

November 9, 2017

[amazon template=image&asin=3319433660]

This book covers all aspects of the diagnosis and treatment of tumors of the jugular foramen – cranial base lesions that present particular diagnostic and management difficulties and remain challenging to remove despite advances in surgery and interventional neuroradiology. The authors have developed novel concepts and surgical techniques relating to management of the facial nerve, reconstruction of the cranial base, and resection of large tumors with intra- and extracranial extension. These techniques, as well as anatomic studies in cadavers, are presented by means of surgical photographs, illustrations, and videos. Tumors of the Jugular Foramen will be of interest to all specialists involved in the management of these challenging tumors, including neurosurgeons, ENT surgeons, neuroradiologists, neurologists, neurointensivists, radiotherapists, oncologists, and physiotherapists.

About the Author

Ricardo Ramina, MD, PhD, studied medicine at the Pontifical Catholic University in Curitiba, Brazil, before completing residencies in neurosurgery in Curitiba, Frankfurt, and Hannover. In 1986 he was appointed Chairman of the Neurosurgical Department at Nações Hospital in Curitiba, Brazil and since 2004 he has been Chairman of the Neurosurgical Department of the Neurological Institute of Curitiba [WFNS (World Federation of Neurosurgical Societies) Post-Graduate Training Center]. Since 2006 he has been Professor of the Postgraduate Course in Surgery at the Pontifical Catholic University of Curitiba, having previously been an Associated Professor of Neurosurgery at George Washington University, Washington and State University of Campinas, São Paulo, Brazil. He has published more than 160 papers in peer-reviewed journals and has given more than 600 lectures and presentations on various topics in neurosurgery as an invited guest or guest of honor at national and international congresses.

Marcos S. Tatagiba, MD, PhD, studied medicine at the University of the State of Rio de Janeiro, Brazil, before undertaking neurosurgical training from 1987 to 1993 in the Department of Neurosurgery, Nordstadt Hospital, Hannover, Germany, under the chairmanship of Prof. Madjid Samii. He presented his doctoral and post-doctoral theses at Hannover Medical School in 1992 and 1998. Since 2000 he has been Vice Director of the International Neuroscience Institute, Hannover; Vice Director of the Department of Neurosurgery, University of Freiburg; Director and Chairman of the Department of Neurosurgery, University of Tübingen; and Chairman and Director, Department of Neurosurgery, University of Zurich. Professor Tatagiba is the author of 237 articles in peer-reviewed journals and the recipient of several prizes, including the Neurosurgical Research Foundation Prize from the German Society of Neurosurgery (2002) and the Innovationspreis Medizintechnik – BMBF (2007). Professor Tatagiba served as President of the German Academy of Neurosurgery in 2010-11 and is President-elect of the German Society of the Skull Base.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FiCfwvx

Contemporary Oral Oncology: Rehabilitation and Supportive Care 1st ed. 2017 Edition

November 9, 2017

[amazon template=image&asin=3319438557]

This is the last of four volumes that together offer an authoritative, in-depth reference guide covering all aspects of the management of oral cancer from a multidisciplinary perspective and on the basis of a strong scientific foundation. This volume focuses on the topic of comprehensive rehabilitation and supportive care in oral cancer. The coverage includes the role of maxillofacial prosthodontics, advances in anaplastology techniques, and management of oral mucositis during radiation and chemotherapy. Holistic and supportive care approaches are discussed, and advice is provided on post-therapy surveillance and the use of different measures to assess quality of life. Nutritional evaluation and management and issues relating to healthcare economics are also considered. This volume will be of interest both to practicing specialists and to ancillary service staff involved in the care of oral cancer patients.

About the Author

Moni Abraham Kuriakose, BSc, BDS, MB ChB, MD, FDSRCS, FFDRCS, FRCS Ed, FRCS (Maxillofacial Surgery), is Director of the Translational Research Program and Attending Surgeon in the Department of Head and Neck/Plastic and Reconstructive Surgery at the Roswell Park Cancer Institute, Buffalo, New York, and Professor of Surgery, Director of the Department of Surgical Oncology, and Chief of the Division of Head and Neck Oncology at the Mazumdar-Shaw Cancer Center, Narayana Health City, Bangalore, India. In addition, he is Adjunct Associate Professor in the Departments of Oral and Maxillofacial Surgery and Otolaryngology at New York University. Dr. Kuriakose has received numerous honors and awards and has held many national and international leadership positions, including as Chairman of the Oral Cancer Special Interest Group, International Association of Oral and Maxillofacial Surgeons (2008-2012), Secretary General of the International Academy of Oral Oncology (2013-2015) and President of Indian Head and Neck Oncology Society (2015-2017). He is a member of the editorial boards for Oral Oncology and the Journal of Maxillofacial and Oral Surgery, and a reviewer for a number of other leading journals. Dr. Kuriakose’s research group focuses on two key challenges: down-staging and prevention of oral cancer; and reversing chemotherapy resistance. He has been the principal investigator on many research projects and is the author of over 150 peer-reviewed publications.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/Fid3dwU

Oncology

Management of the Patient at High Risk for Breast Cancer

November 7, 2017

[amazon template=image&asin=1461458900]

Management of the Patient at High Risk for Breast Cancer provides a state-of-the art review of patients who are at high risk for breast cancer, how to identify them, the tools available for risk assessment and quantification and indications for genetic counseling and testing. The book summarizes the high risk breast imaging options, including newest techniques and schedules. Pathologic evaluation of high risk lesions are featured as well as the management issues surrounding these lesions. The volume also covers the management of concomitant cancer risk and screening strategies.

A concise, yet comprehensive overview of the current status of the topic, Management of the Patient at High Risk for Breast Cancer serves as a useful resource for physicians and researchers dealing with and interested in patients at high risk for breast cancer.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FgrZveN

Oncology

Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications

November 7, 2017

[amazon template=image&asin=1461461812]

Recent studies demonstrated a key role of the androgen receptor in the development of castration-recurrent or -resistant prostate cancer (CRPC), which is deadly and in urgent need of more effective therapies. Understanding the functions of androgen-responsive genes and their regulation and deregulation in prostate cancer progression may lead to new approaches to prevent and treat prostate cancer patients.

This book provides an up-to-date review of the overall androgen-responsive gene expression program and the regulation, function, and clinical relevance of both protein coding and non-coding androgen-responsive genes. Experts in the field of androgen action and prostate cancer research discussed the importance of DNA elements, chromatin structure, cellular signaling, and cell-cell interactions in the regulation of androgen-responsive genes in the context of prostate cancer progression, including the development of CRPC. This book is intended for individuals interested in cancer endocrinology and medical and healthcare professionals involved in prostate cancer research.

About the Author

The volume editor, Dr. Zhou Wang, is well-noted in the field of prostate cancer and he is theChair for Urological Research at the University of Pittsburgh Medical Center, as well as the co-director of Urological and Prostate Cancer Program at the University of Pittsburgh Cancer Institute.He has also conducted several scientific reviews for several top journals in the area of cancer research.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/Fgr8dTR

Merkel Cell Carcinoma

November 7, 2017

[amazon template=image&asin=1461466075]

Features:

· Comprehensive single-source clinical reference

· Treatment focus

· Written for practitioners, with emphasis on clinical relevance and quick retrieval of information

· Contributing authors represent all disciplines involved in treatment of Merkel cell carcinoma: dermatology, surgical oncology, radiation oncology, and medical oncology

· International in perspective, with contributors from US and abroad

· Members of active Merkel Cell Carcinoma Multicenter Interest Group have authored some of the chapters

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FgrbAKW

Oncology

146650370X

November 7, 2017

[amazon template=image&asin=146650370X]

Increasing scientific evidence suggests that the majority of diseases including cancer are driven by oxidative stress and inflammation, attributed to environmental factors. These factors either drive genetic mutations or epigenetically modify expression of key regulatory genes. These changes can occur as early as gestational fetal development, and major questions remain as to how dietary/nutritional phytochemical factors biochemically interact with such genetic and epigenetic events. With chapters written by international experts, Inflammation, Oxidative Stress, and Cancer: Dietary Approaches for Cancer Prevention examines the latest developments on the effects of various dietary phytochemicals.

Divided into nine sections, the book begins with the basic mechanisms of inflammation/oxidative stress-driven cancer, including an overview of the topic and how to prevent carcinogenesis, the role of obesity in inflammation and cancer, and antioxidant properties of some common dietary phytochemicals. Subsequent sections cover cellular signal transduction, molecular targets, and biomarkers of dietary cancer-preventive phytochemicals, as well as their potential challenges with in vivo absorption and pharmacokinetics.

The chapters also examine the cancer-preventive properties of various classes of phytochemicals, including vitamins A, D, and E; omega-3 and omega-6 fatty acids; flavanoids and polyphenols; garlic organosulfur compounds and cruciferous glucosinolates; and selenium, traditional Chinese herbal medicines, and alpha lipoic acid. The final section of the book explores the latest developments on the interactions of dietary phytochemicals through epigenetics and the management of chronic inflammation with nutritional phytochemicals.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FgYw4BT

Practical Management of Thyroid Cancer: A Multidisciplinary Approach

November 6, 2017

[amazon template=image&asin=1852339101]

Practical Management of Thyroid Cancer follows the American and European model of treating thyroid cancer according to the high standards recommended by the available guidelines. All rare and curable cancers including thyroid cancers with a good prognosis should be treated by a multidisciplinary team of experts following published guidelines. This essential volume is therefore directed not only to the management of thyroid cancer in developed countries but is also the model that will be highly attractive to the developing countries.

This is an invaluable reference to health care professionals, from primary to tertiary care, involved in the management of thyroid cancer such as clinical nurse specialists, clinical psychologists, family medicine practitioners, specialists in palliative care (especially for anaplastic thyroid cancers), genetics as well as surgeons, endocrinologists, oncologists, pathologists, and radiologists.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/Fg5txEC

Molecular Determinants of Head and Neck Cancer (Current Cancer Research)

November 5, 2017

[amazon template=image&asin=1461488141]

Head and neck cancers, involving sites from the nasopharynx to the subglottic larynx, are frequently devastating cancers that afflict patients around the world. These cancers are frequently locally advanced prior to detection, and require multimodality therapy that is associated with high morbidity. As this book addresses this difficult disease, it accomplishes three main goals.

First, it introduces the etiology and subclasses of squamous cell carcinomas of the head and neck (SCCHNs), and how these factors affect prognosis. Although habitual exposures to tobacco, alcohol, and other agents have historically been the main causes of SCCHN, a rising proportion of oropharynx cancers arise from transforming human papillomavirus (HPV) infection. These two broad classes of SCCHN have significant differences in disease profile and response to treatment, as we discuss.

Second, it summarizes the current state of understanding of the genetic, epigenetic and protein expression changes associated with the various classes of SCCHN. In the past decade, disease pathogenesis of SCCHN has been appreciated to involve deregulation of multiple tumor pathways, including the receptor tyrosine kinases (RTKs) EGFR, ERBB2, ERBB3, c-MET, and IGF1R; transforming growth factor β (TGFβ); Notch; cytoplasmic signaling proteins including PTEN, PI3K, JAK/STAT, and Wnt-responsive β-catenin; mutation control systems, including p53 and the DNA damage repair (DDR) machinery; and hypoxic response. The specific understanding of the action of these proteins in SCCHN is presented here.

Finally, this book defines potential therapeutic targets for improved management of the disease in the future, discussing prospects for improved prediction of prognosis.

About the Author

Barbara Burtness, M.D. is Associate Director for Clinical Research at the Fox Chase Cancer Center. She is also a co-leader of the Keystone Program in Head and Neck Cancer. As Chair of the Head and Neck Committee in the Eastern Cooperative Oncology Group and a member of the NCI Head and Neck Steering Committee, she helps shape the national agenda for research on all stages of head and neck cancer.

Erica Golemis, Ph.D. is the Deputy Chief Scientific Officer at the Fox Chase Cancer Center. She is also the Co-Leader of Developmental Therapeutics and Co-Leader of the Head and Neck Cancer Keystone at Fox Chase. Her research seeks to define the changes in cell signaling that occur as tumors spread by metastasis and develop resistance to drugs, with the ultimate goal of inhibiting these processes.

DOWNLOAD THIS BOOK FREE HERE

http://upsto.re/FgssLwe

Oncology

« 1 … 23 24 25 26 27 … 47 »